S. Petersenn, M. Fleseriu, F.F. Casanueva, A. Giustina, N. Biermasz, B.M.K. Biller et al., Diagnosis and management of prolactin-secreting pituitary adenomas: a pituitary society international consensus statement. Nat. Rev. Endocrinol. 19(12), 722–740 (2023)

Article  PubMed  Google Scholar 

P.P. Huynh, L.E. Ishii, M. Ishii, Prolactinomas JAMA 325(2), 195 (2021)

Article  PubMed  Google Scholar 

R. Cozzi, M.R. Ambrosio, R. Attanasio, C. Battista, A. Bozzao, M. Caputo et al., Italian association of clinical endocrinologists (AME) and international chapter of clinical endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors. Eur. J. Endocrinol. 186(3), P1–P33 (2022)

Article  PubMed  PubMed Central  CAS  Google Scholar 

L. Dzialach, J. Sobolewska, Z. Zak, W. Respondek, P. Witek, Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment. Front. Endocrinol. (Lausanne). 15, 1338345 (2024)

Article  PubMed  Google Scholar 

H. Duskin-Bitan, I. Shimon, Prolactinomas in males: any differences? Pituitary 2020, 23(1): 52–57

Y. Rudman, H. Duskin-Bitan, I. Richter, G. Tsvetov, H. Masri-Iraqi, A. Akirov et al., Hemoglobin decline as a signal for hyperprolactinemia onset prior to prolactinoma diagnosis in hypogonadal men. Andrology. 11(7), 1398–1407 (2023)

Article  PubMed  CAS  Google Scholar 

M. Fleseriu, M. Christ-Crain, F. Langlois, M. Gadelha, S. Melmed, Hypopituitarism Lancet. 403(10444), 2632–2648 (2024)

Article  PubMed  CAS  Google Scholar 

S.M. Constantinescu, D. Maiter, O. Alexopoulou, Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists. Pituitary. 27(5), 625–634 (2024)

Article  PubMed  CAS  Google Scholar 

K.M. Al Dahmani, M.H. Almalki, A. Ekhzaimy, F. Aziz, A. Bashier, M.M. Mahzari et al., Proportion and predictors of hypogonadism recovery in men with macroprolactinomas treated with dopamine agonists. Pituitary. 25(4), 658–666 (2022)

Article  PubMed  CAS  Google Scholar 

M. Sehemby, A.R. Lila, V. Sarathi, R. Shah, S. Sankhe, S.K. Jaiswal et al., Predictors of chronic LH-Testosterone axis suppression in male macroprolactinomas with normoprolactinemia on Cabergoline. J. Clin. Endocrinol. Metab. 2020, 105(12)

A. Tirosh, C. Benbassat, A. Lifshitz, I. Shimon, Hypopituitarism patterns and prevalence among men with macroprolactinomas. Pituitary. 18(1), 108–115 (2015)

Article  PubMed  CAS  Google Scholar 

Y. Rudman, N. Simon, R. Shimon, G. Drozdinsky, E. Markus, H. Duskin-Bitan et al., Response to Cabergoline treatment, gonadal axis recovery, and outcomes of drug withdrawal, in men with microprolactinoma: a retrospective cohort study. Endocrine. 89(1), 212–221 (2025)

Article  PubMed  PubMed Central  CAS  Google Scholar 

Y. Rudman, H. Duskin-Bitan, H. Masri-Iraqi, A. Akirov, I. Shimon, Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma. Pituitary. 25(6), 882–890 (2022)

Article  PubMed  CAS  Google Scholar 

M. Fleseriu, I.A. Hashim, N. Karavitaki, S. Melmed, M.H. Murad, R. Salvatori et al., Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(11), 3888–3921 (2016)

Article  PubMed  CAS  Google Scholar 

F. Haidenberg-David, J. Sidauy-Adissi, A. Moscona-Nissan, E. Jonguitud-Zumaya, M. Fugarolas-Morinelli, F. Martinez-Mendoza et al., Overview of hyperprolactinemia: general approach and reproductive health implications. Arch. Med. Res. 55(8), 103102 (2024)

Article  PubMed  CAS  Google Scholar 

L. Billion, A. Verleye, C. Block, P.V. Heyning, C. Herdt, Giant prolactinomas, a detailed analysis of 196 adult cases. Pituitary. 26(5), 529–537 (2023)

Article  PubMed  Google Scholar 

R. Hamblin, A. Fountas, K. Lithgow, P.B. Loughrey, E. Bonanos, S.K. Shinwari et al., Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium. Eur. J. Endocrinol. 189(1), 87–95 (2023)

Article  PubMed  CAS  Google Scholar 

De M. Rosa, A. Ciccarelli, S. Zarrilli, E. Guerra, M. Gaccione, Di A. Sarno et al., The treatment with Cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. Clin. Endocrinol. (Oxf). 64(3), 307–313 (2006)

Article  PubMed  Google Scholar 

S. Hofbauer, L. Horka, S. Seidenberg, R. Da Mutten, L. Regli, C. Serra et al., Metabolic and inflammatory parameters in relation to baseline characterization and treatment outcome in patients with prolactinoma: insights from a retrospective cohort study at a single tertiary center. Front. Endocrinol. (Lausanne). 15, 1363939 (2024)

Article  PubMed  Google Scholar 

A.S. Posawetz, C. Trummer, M. Pandis, F. Aberer, T.R. Pieber, B. Obermayer-Pietsch et al., Adverse body composition and lipid parameters in patients with prolactinoma: a case-control study. BMC Endocr. Disord. 21(1), 81 (2021)

Article  PubMed  PubMed Central  CAS  Google Scholar 

Y. Macotela, J. Triebel, C. Clapp, Time for a new perspective on prolactin in metabolism. Trends Endocrinol. Metab. 31(4), 276–286 (2020)

Article  PubMed  CAS  Google Scholar 

A.L. Goldman, S. Bhasin, F.C.W. Wu, M. Krishna, A.M. Matsumoto, R. Jasuja, A reappraisal of testosterone’s binding in circulation: physiological and clinical implications. Endocr. Rev. 38(4), 302–324 (2017)

Article  PubMed  PubMed Central  Google Scholar 

C. Li, E.S. Ford, B. Li, W.H. Giles, S. Liu, Association of testosterone and sex hormone-binding Globulin with metabolic syndrome and insulin resistance in men. Diabetes Care. 33(7), 1618–1624 (2010)

Article  PubMed  PubMed Central  CAS  Google Scholar